CD8A and infection: We observed a comparable number of DbGP33 and DbGP276 tetramer+ CD8+ T cells as well as PD-1+CD8+ T cells, most of which are LCMV specific, 10 days after infection between control and rapamycin-treated mice (Figure 1A).